Jessika Bertacchini

1.7k total citations
52 papers, 1.2k citations indexed

About

Jessika Bertacchini is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Jessika Bertacchini has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 12 papers in Biomedical Engineering and 8 papers in Oncology. Recurrent topics in Jessika Bertacchini's work include Bone Tissue Engineering Materials (8 papers), Nuclear Structure and Function (7 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Jessika Bertacchini is often cited by papers focused on Bone Tissue Engineering Materials (8 papers), Nuclear Structure and Function (7 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Jessika Bertacchini collaborates with scholars based in Italy, United States and Iran. Jessika Bertacchini's co-authors include Sandra Marmiroli, Laura Mediani, Najmaldin Saki, Silvano Capitani, Mohammad Shahjahani, Ahmad Ahmadzadeh, Maria Ruzzene, Anto De Pol, Tullia Maraldi and Laura Anselmi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and The FASEB Journal.

In The Last Decade

Jessika Bertacchini

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jessika Bertacchini Italy 19 747 176 173 150 146 52 1.2k
Anna C. Berardi Italy 21 485 0.6× 97 0.6× 357 2.1× 170 1.1× 182 1.2× 63 1.5k
Ester Orsini Italy 21 399 0.5× 333 1.9× 222 1.3× 137 0.9× 132 0.9× 34 1.3k
Yan Han China 20 855 1.1× 422 2.4× 259 1.5× 136 0.9× 147 1.0× 40 1.8k
Gurudutta Gangenahalli India 19 542 0.7× 200 1.1× 145 0.8× 160 1.1× 361 2.5× 49 1.3k
Sanja Aveic Italy 19 440 0.6× 187 1.1× 90 0.5× 140 0.9× 63 0.4× 48 915
Dadi Jin China 22 805 1.1× 207 1.2× 49 0.3× 323 2.2× 127 0.9× 89 1.8k
Vimal Kishor Singh India 16 633 0.8× 186 1.1× 71 0.4× 100 0.7× 306 2.1× 29 1.2k
Peter Vanderslice United States 25 665 0.9× 175 1.0× 109 0.6× 146 1.0× 192 1.3× 47 1.6k
Atul Kumar India 14 272 0.4× 141 0.8× 73 0.4× 153 1.0× 159 1.1× 22 771
Duohui Jing Germany 14 274 0.4× 117 0.7× 287 1.7× 172 1.1× 292 2.0× 22 905

Countries citing papers authored by Jessika Bertacchini

Since Specialization
Citations

This map shows the geographic impact of Jessika Bertacchini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessika Bertacchini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessika Bertacchini more than expected).

Fields of papers citing papers by Jessika Bertacchini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessika Bertacchini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessika Bertacchini. The network helps show where Jessika Bertacchini may publish in the future.

Co-authorship network of co-authors of Jessika Bertacchini

This figure shows the co-authorship network connecting the top 25 collaborators of Jessika Bertacchini. A scholar is included among the top collaborators of Jessika Bertacchini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessika Bertacchini. Jessika Bertacchini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cenni, Vittoria, Alberto Bavelloni, Cristina Capanni, et al.. (2025). ANKRD2 Knockdown as a Therapeutic Strategy in Osteosarcoma: Effects on Proliferation and Drug Response in U2OS and HOS Cells. International Journal of Molecular Sciences. 26(4). 1736–1736.
2.
Zardin, Barbara, et al.. (2024). Evaluating Laser‐Based Microfabrication in Microfluidics: An Experimental and Computational Trial. Advanced Engineering Materials. 26(21). 1 indexed citations
3.
Pisciotta, Alessandra, Laura Bertoni, Paola Sena, et al.. (2024). Zirconia Hybrid Dental Implants Influence the Biological Properties of Neural Crest-Derived Mesenchymal Stromal Cells. Nanomaterials. 14(5). 392–392. 4 indexed citations
4.
Cenni, Vittoria, Manuela Piazzi, Michele Signore, et al.. (2024). Myoblast-Derived Galectin 3 Impairs the Early Phases of Osteogenesis Affecting Notch and Akt Activity. Biomolecules. 14(10). 1243–1243. 2 indexed citations
5.
D'Adamo, Alessandro, et al.. (2023). Experimental measurements and CFD modelling of hydroxyapatite scaffolds in perfusion bioreactors for bone regeneration. Regenerative Biomaterials. 10. rbad002–rbad002. 8 indexed citations
6.
Bertoni, Laura, Alessandra Pisciotta, Roberto Rosà, et al.. (2023). Flow-dependent shear stress affects the biological properties of pericyte-like cells isolated from human dental pulp. Stem Cell Research & Therapy. 14(1). 31–31. 15 indexed citations
7.
Remondini, Daniel, et al.. (2021). Mechanisms Involved in the Promoting Activity of Fibroblasts in HTLV-1-Mediated Lymphomagenesis: Insights into the Plasticity of Lymphomatous Cells. International Journal of Molecular Sciences. 22(19). 10562–10562. 1 indexed citations
8.
Sperduti, Samantha, Clara Lazzaretti, Laura Riccetti, et al.. (2019). GnRH Antagonists Produce Differential Modulation of the Signaling Pathways Mediated by GnRH Receptors. International Journal of Molecular Sciences. 20(22). 5548–5548. 12 indexed citations
9.
Shahrabi, Saeid, et al.. (2018). Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response. Biochemical Genetics. 56(3). 149–175. 14 indexed citations
10.
Bertacchini, Jessika, Chiara Frasson, Francesca Chiarini, et al.. (2018). Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells. Advances in Biological Regulation. 68. 2–9. 16 indexed citations
11.
Morelli, Federica, Dineke S. Verbeek, Jessika Bertacchini, et al.. (2017). Aberrant Compartment Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and Function. Cell Reports. 20(9). 2100–2115. 38 indexed citations
12.
Ruzzene, Maria, Jessika Bertacchini, Alex Toker, & Sandra Marmiroli. (2017). Cross-talk between the CK2 and AKT signaling pathways in cancer. Advances in Biological Regulation. 64. 1–8. 48 indexed citations
13.
Bertacchini, Jessika, et al.. (2015). Inhibition of Ras-mediated signaling pathways in CML stem cells. Cellular Oncology. 38(6). 407–418. 15 indexed citations
14.
Bertacchini, Jessika, Marianna Guida, Benedetta Accordi, et al.. (2014). Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis. Leukemia. 28(11). 2197–2205. 56 indexed citations
15.
Marmiroli, Sandra, Jessika Bertacchini, Francesca Beretti, et al.. (2009). A‐type lamins and signaling: The PI 3‐kinase/Akt pathway moves forward. Journal of Cellular Physiology. 220(3). 553–561. 40 indexed citations
16.
Sena, Paola, Massimo Riccio, Laura Marzona, et al.. (2009). Human MATER localization in specific cell domains of oocytes and follicular cells. Reproductive BioMedicine Online. 18(2). 226–234. 18 indexed citations
17.
Maraldi, Tullia, M. Riccio, Paola Sena, et al.. (2009). MATER protein as substrate of PKC  in human cumulus cells. Molecular Human Reproduction. 15(8). 499–506. 24 indexed citations
18.
Verdelli, Donata, Lucia Nobili, Katia Todoerti, et al.. (2008). Molecular targeting of the PKC‐β inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression. Hematological Oncology. 27(1). 23–30. 17 indexed citations
19.
Neri, Antonino, Sandra Marmiroli, Pierfrancesco Tassone, et al.. (2008). The oral protein-kinase Cβinhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines. Leukemia & lymphoma. 49(7). 1374–1383. 33 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna C. Berardi Breakdown of academic impact, for papers by Ester Orsini Breakdown of academic impact, for papers by Yan Han Breakdown of academic impact, for papers by Gurudutta Gangenahalli Breakdown of academic impact, for papers by Sanja Aveic Breakdown of academic impact, for papers by Dadi Jin Breakdown of academic impact, for papers by Vimal Kishor Singh Breakdown of academic impact, for papers by Peter Vanderslice Breakdown of academic impact, for papers by Atul Kumar Breakdown of academic impact, for papers by Duohui Jing
Rankless by CCL
2026